Vanda Pharmaceuticals Inc (VNDA) — Strategic Asset Allocation Index
Vanda Pharmaceuticals Inc (VNDA) has a Strategic Asset Allocation Index of 0.4% as of June 2023. Strategic assets (PP&E of $2.16 Million plus long-term investments of $-) total $2.16 Million, measured against net assets of $539.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Vanda Pharmaceuticals Inc Strategic Asset Allocation Index (2004–2022)
This chart shows how Vanda Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 19 annual periods from 2004 to 2022. As of June 2023, the index stands at 0.4%, representing strategic assets of $2.16 Million against net assets of $539.90 Million USD. Explore cash flow conversion of Vanda Pharmaceuticals Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Vanda Pharmaceuticals Inc (2004–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Vanda Pharmaceuticals Inc from 2004 to 2022, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see VNDA stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.5% | $2.57 Million | $2.57 Million | $- | $527.20 Million | ▼ -2.0 pp |
| 2021 | 2.5% | $12.38 Million | $12.38 Million | $- | $504.93 Million | ▲ +1.5 pp |
| 2020 | 0.9% | $4.14 Million | $4.14 Million | $- | $453.27 Million | ▼ 0.0 pp |
| 2019 | 0.9% | $3.86 Million | $3.86 Million | $- | $410.94 Million | ▼ -0.7 pp |
| 2018 | 1.6% | $4.42 Million | $4.42 Million | $- | $275.42 Million | ▼ -2.4 pp |
| 2017 | 4.0% | $5.31 Million | $5.31 Million | $- | $131.39 Million | ▲ +0.2 pp |
| 2016 | 3.8% | $5.01 Million | $5.01 Million | $- | $131.33 Million | ▲ +0.4 pp |
| 2015 | 3.4% | $4.57 Million | $4.57 Million | $- | $133.03 Million | ▲ +1.9 pp |
| 2014 | 1.5% | $2.44 Million | $2.44 Million | $- | $160.82 Million | ▼ -3.5 pp |
| 2013 | 5.0% | $2.20 Million | $2.20 Million | $- | $44.12 Million | ▼ -18.7 pp |
| 2012 | 23.7% | $2.35 Million | $2.35 Million | $- | $9.90 Million | ▼ -36.0 pp |
| 2011 | 59.7% | $19.98 Million | $964.00K | $19.01 Million | $33.47 Million | ▲ +57.2 pp |
| 2010 | 2.5% | $937.00K | $937.00K | $- | $37.73 Million | ▼ -3.2 pp |
| 2009 | 5.7% | $1.32 Million | $1.32 Million | $- | $23.03 Million | ▲ +1.9 pp |
| 2008 | 3.8% | $1.76 Million | $1.76 Million | $- | $46.02 Million | ▲ +2.2 pp |
| 2007 | 1.6% | $1.35 Million | $1.35 Million | $- | $83.73 Million | ▼ -5.3 pp |
| 2006 | 7.0% | $1.86 Million | $1.86 Million | $- | $26.76 Million | ▲ +3.3 pp |
| 2005 | 3.6% | $1.11 Million | $1.11 Million | $- | $30.66 Million | ▼ -4.2 pp |
| 2004 | 7.9% | $1.25 Million | $1.25 Million | $- | $15.94 Million | — |